Business Description
Vimab Group AB
ISIN : SE0007439633
Total Employee Number:
176Compare
Compare
Traded in other countries / regions
VIMAB.SwedenNM4.Germany IPO Date
2015-10-02Description
Vimab Group AB is a Nordic company helping companies with transformation and improvement initiatives. It offers services including Interim management, Executive search.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.14 | |||||
Equity-to-Asset | 0.06 | |||||
Debt-to-Equity | 8.02 | |||||
Debt-to-EBITDA | -3.81 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.36 | |||||
Beneish M-Score | -3.89 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -19 | |||||
3-Year EBITDA Growth Rate | -18.7 | |||||
3-Year EPS without NRI Growth Rate | -111 | |||||
3-Year FCF Growth Rate | -104.9 | |||||
3-Year Book Growth Rate | -22.5 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 77.24 | |||||
9-Day RSI | 67.28 | |||||
14-Day RSI | 61.05 | |||||
3-1 Month Momentum % | 17.65 | |||||
6-1 Month Momentum % | -14.11 | |||||
12-1 Month Momentum % | -61.11 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.71 | |||||
Quick Ratio | 0.44 | |||||
Cash Ratio | 0.07 | |||||
Days Inventory | 184.19 | |||||
Days Sales Outstanding | 20.38 | |||||
Days Payable | 191.13 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -11 | |||||
Shareholder Yield % | 23.89 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 67.03 | |||||
Operating Margin % | -21.77 | |||||
Net Margin % | -28.45 | |||||
EBITDA Margin % | -9.2 | |||||
FCF Margin % | -17.25 | |||||
OCF Margin % | -17.25 | |||||
ROE % | -995.52 | |||||
ROA % | -36.63 | |||||
ROIC % | -23.88 | |||||
3-Year ROIIC % | -64.22 | |||||
ROC (Joel Greenblatt) % | -162.07 | |||||
ROCE % | -276.15 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 10.53 | |||||
PS Ratio | 0.26 | |||||
PB Ratio | 9.94 | |||||
EV-to-EBIT | -1.95 | |||||
EV-to-Forward-EBIT | 1.71 | |||||
EV-to-EBITDA | -4.61 | |||||
EV-to-Revenue | 0.42 | |||||
EV-to-Forward-Revenue | 0.54 | |||||
EV-to-FCF | -2.27 | |||||
Price-to-GF-Value | 0.49 | |||||
Price-to-Projected-FCF | 3.62 | |||||
Price-to-Median-PS-Value | 0.48 | |||||
Earnings Yield (Greenblatt) % | -51.35 | |||||
FCF Yield % | -39.79 | |||||
Forward Rate of Return (Yacktman) % | 230.6 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vimab Group AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 325.739 | ||
| EPS (TTM) (kr) | -3.2 | ||
| Beta | -2.2322 | ||
| 3-Year Sharpe Ratio | -0.19 | ||
| 3-Year Sortino Ratio | -0.31 | ||
| Volatility % | 76.31 | ||
| 14-Day RSI | 61.05 | ||
| 14-Day ATR (kr) | 0.098887 | ||
| 20-Day SMA (kr) | 2.76 | ||
| 12-1 Month Momentum % | -61.11 | ||
| 52-Week Range (kr) | 1.79 - 8.2 | ||
| Shares Outstanding (Mil) | 47.56 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vimab Group AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vimab Group AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-06 | In 115 days | ||
| Second quarter earnings results for 2026 | 2026-08-28 | In 45 days | ||
| General meeting for 2026 | 2026-06-09 10:00 | 2.78 (-3.47%) | ||
| Annual report for 2025 | 2026-05-20 | 3.02 (+0.33%) | ||
| First quarter earnings results for 2026 | 2026-05-14 | 3.00 (+3.45%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-12 | 1.91 (+0.53%) | ||
| Third quarter earnings results for 2025 | 2025-11-07 | 5.00 (-11.66%) | ||
| Second quarter earnings results for 2025 | 2025-08-28 | 7.46 (+2.47%) | ||
| General meeting for 2025 | 2025-06-10 10:00 | 7.80 (-2.74%) | ||
| Annual report for 2024 | 2025-05-23 | 7.70 (-2.78%) |
Show
Entries
Vimab Group AB Frequently Asked Questions
What is Vimab Group AB(OSTO:VIMAB)'s stock price today?
The current price of OSTO:VIMAB is kr2.97. The 52 week high of OSTO:VIMAB is kr8.20 and 52 week low is kr1.79.
When is next earnings date of Vimab Group AB(OSTO:VIMAB)?
The next earnings date of Vimab Group AB(OSTO:VIMAB) is 2026-08-28 Est..
Does Vimab Group AB(OSTO:VIMAB) pay dividends? If so, how much?
Vimab Group AB(OSTO:VIMAB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Vimab Group AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers